The United Kingdom is experiencing a significant evolution in its attitude towards entheogens. What began with a emerging exploration of ‘shrooms’ and commonplace Ayahuasca is increasingly developing to feature lesser-known substances like copyright and potentially investigations into therapeutic uses. This developing interest is powered by bot